PTC Therapeutics, Inc. (PTCT)
62.33
-1.00
(-1.58%)
USD |
NASDAQ |
Mar 06, 10:18
PTC Therapeutics Research and Development Expense (TTM) : 455.25M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Sarepta Therapeutics, Inc. | 1.516B |
| Ardelyx, Inc. | 68.47M |
| Spyre Therapeutics, Inc. | 171.65M |
| Ovid Therapeutics, Inc. | 24.66M |